Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $10,675 - $12,781
-87 Reduced 0.59%
14,784 $2.11 Million
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $374,845 - $498,962
-3,671 Reduced 19.8%
14,871 $1.91 Million
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $1.06 Million - $1.27 Million
12,061 Added 186.1%
18,542 $1.92 Million
Q3 2023

Nov 09, 2023

SELL
$90.94 - $199.54 $161,600 - $354,582
-1,777 Reduced 21.52%
6,481 $589,000
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $155 - $172
1 Added 0.01%
8,258 $1.34 Million
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $13,234 - $15,913
100 Added 1.23%
8,257 $1.31 Million
Q4 2022

Feb 09, 2023

SELL
$102.55 - $135.33 $299,446 - $395,163
-2,920 Reduced 26.36%
8,157 $1.1 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $288,698 - $354,297
3,030 Added 37.65%
11,077 $1.1 Million
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $516,200 - $609,050
5,000 Added 164.1%
8,047 $897,000
Q1 2022

May 12, 2022

SELL
$93.1 - $112.54 $191,413 - $231,382
-2,056 Reduced 40.29%
3,047 $338,000
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $168,924 - $213,346
2,001 Added 64.51%
5,103 $490,000
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $201,180 - $227,459
-3,000 Reduced 49.16%
3,102 $209,000
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $677,234 - $782,280
-10,600 Reduced 63.47%
6,102 $426,000
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $636,963 - $702,270
10,001 Added 149.25%
16,702 $1.16 Million
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $58 - $67
1 Added 0.01%
6,701 $439,000
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $334,062 - $390,342
6,700 New
6,700 $388,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track King Wealth Portfolio

Follow King Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.